Mingkai Yu

486 total citations
25 papers, 265 citations indexed

About

Mingkai Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mingkai Yu has authored 25 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mingkai Yu's work include vaccines and immunoinformatics approaches (6 papers), Animal Virus Infections Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Mingkai Yu is often cited by papers focused on vaccines and immunoinformatics approaches (6 papers), Animal Virus Infections Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Mingkai Yu collaborates with scholars based in China, United States and Canada. Mingkai Yu's co-authors include Mark A. Wainberg, E Israël, Jianbing Ding, Fengbo Zhang, Yuejie Zhu, Zhiqiang Chen, Yujiao Li, Tong Sha, Xinru Xie and Wenhong Guo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Mingkai Yu

23 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingkai Yu China 10 135 65 58 43 34 25 265
K Sletten Norway 12 342 2.5× 32 0.5× 31 0.5× 56 1.3× 12 0.4× 19 485
Leimarembi Devi Naorem India 10 347 2.6× 44 0.7× 59 1.0× 39 0.9× 9 0.3× 22 458
Md. Jahirul Islam Bangladesh 9 148 1.1× 25 0.4× 21 0.4× 29 0.7× 7 0.2× 20 291
Jasmine Lin United States 7 85 0.6× 30 0.5× 11 0.2× 12 0.3× 14 0.4× 16 240
Miren Josu Omaetxebarria Ibarra Spain 11 180 1.3× 60 0.9× 44 0.8× 152 3.5× 23 0.7× 19 432
Radoslaw P. Kozak United Kingdom 14 525 3.9× 106 1.6× 158 2.7× 29 0.7× 8 0.2× 20 600
Karl-Anders Karlsson Sweden 11 231 1.7× 58 0.9× 42 0.7× 13 0.3× 13 0.4× 14 329
Sumit Mukherjee Israel 14 301 2.2× 57 0.9× 30 0.5× 91 2.1× 6 0.2× 40 521
Minjie Meng China 12 147 1.1× 78 1.2× 8 0.1× 43 1.0× 13 0.4× 24 370
Aqsa Ikram Pakistan 12 228 1.7× 63 1.0× 49 0.8× 74 1.7× 3 0.1× 27 401

Countries citing papers authored by Mingkai Yu

Since Specialization
Citations

This map shows the geographic impact of Mingkai Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingkai Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingkai Yu more than expected).

Fields of papers citing papers by Mingkai Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingkai Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingkai Yu. The network helps show where Mingkai Yu may publish in the future.

Co-authorship network of co-authors of Mingkai Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingkai Yu. A scholar is included among the top collaborators of Mingkai Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingkai Yu. Mingkai Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Mingkai, Tao Ma, Wenhao Weng, et al.. (2025). SIRT3 mitigates osteoarthritis by suppressing ferroptosis through activating AMPK signaling pathway. Cellular Signalling. 135. 112063–112063.
2.
3.
Yu, Mingkai, et al.. (2024). Serum TNF-α level and probing depth as a combined indicator for peri-implant disease. Brazilian Journal of Medical and Biological Research. 57. e12989–e12989. 3 indexed citations
4.
Yu, Mingkai, Haixia Yu, Hongmei Wang, et al.. (2024). Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review). International Journal of Oncology. 65(4). 7 indexed citations
5.
Li, Min, et al.. (2024). Designing a conjugate vaccine targeting Klebsiella pneumoniae ST258 and ST11. Heliyon. 10(5). e27417–e27417. 4 indexed citations
6.
Zhu, Yuejie, et al.. (2023). Bioinformatics-based design of a fusion vaccine with CTLA-4 variable region to combat Brucella. Brazilian Journal of Medical and Biological Research. 56. e12938–e12938. 1 indexed citations
7.
Pang, Nannan, et al.. (2023). The level of Tim-3+CD8+ T cells can serve as a potential marker for evaluating the severity of acute graft-versus-host disease after haplo-PBSCT. Brazilian Journal of Medical and Biological Research. 56. e12997–e12997. 1 indexed citations
8.
Li, Min, Mingkai Yu, Xinru Xie, et al.. (2023). Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS). PLoS ONE. 18(8). e0286358–e0286358. 12 indexed citations
9.
Zhu, Yuejie, Mingkai Yu, Chuntao Zhang, et al.. (2023). Contriving a novel of CHB therapeutic vaccine based on IgV_CTLA-4 and L protein via immunoinformatics approach. Journal of Biomolecular Structure and Dynamics. 42(12). 6323–6341. 3 indexed citations
10.
Li, Min, Yuejie Zhu, Xinru Xie, et al.. (2022). Design of a multi-epitope vaccine candidate against Brucella melitensis. Scientific Reports. 12(1). 10146–10146. 41 indexed citations
11.
Yu, Mingkai, Yuejie Zhu, Yujiao Li, et al.. (2022). Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches. Frontiers in Immunology. 13. 884433–884433. 27 indexed citations
12.
Yu, Mingkai, Yuejie Zhu, Yujiao Li, et al.. (2021). Design of a Novel Multi-Epitope Vaccine Against Echinococcus granulosus in Immunoinformatics. Frontiers in Immunology. 12. 668492–668492. 31 indexed citations
13.
Li, Yujiao, Yuejie Zhu, Tong Sha, et al.. (2021). A Multi-Epitope Chitosan Nanoparticles Vaccine ofCanine AgainstEchinococcus granulosus. Journal of Biomedical Nanotechnology. 17(5). 910–920. 9 indexed citations
14.
15.
Smith, Matthew R., Danièle Ouellet, Hiroji Uemura, et al.. (2018). Relationship between apalutamide (APA) exposure and metastasis-free survival (MFS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from SPARTAN. Annals of Oncology. 29. viii278–viii278. 1 indexed citations
16.
Bossi, Alberto, David P. Dearnaley, Michael McKenzie, et al.. (2016). ATLAS: A phase 3 trial evaluating the efficacy of apalutamide (ARN-509) in patients with high-risk localized or locally advanced prostate cancer receiving primary radiation therapy. Annals of Oncology. 27. vi263–vi263. 3 indexed citations
17.
18.
Israël, E, Mingkai Yu, & Mark A. Wainberg. (1979). Non-specific effects of avian retrovirus co-incubation on lymphocyte function: abrogation of antigen- and mitogen-induced proliferative responsiveness.. PubMed. 38(1). 41–50. 20 indexed citations
19.
Wainberg, Mark A., et al.. (1977). Cellular and humoral anti‐tumor immune responsiveness in chickens bearing tumors induced by avian sarcoma virus. International Journal of Cancer. 19(5). 680–687. 17 indexed citations
20.
Scriabine, Alexander, et al.. (1961). Pharmacological Studies with Polythiazide, a New Diuretic and Antihypertensive Agent.. Experimental Biology and Medicine. 107(4). 864–872. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Sletten Breakdown of academic impact, for papers by Leimarembi Devi Naorem Breakdown of academic impact, for papers by Md. Jahirul Islam Breakdown of academic impact, for papers by Jasmine Lin Breakdown of academic impact, for papers by Miren Josu Omaetxebarria Ibarra Breakdown of academic impact, for papers by Radoslaw P. Kozak Breakdown of academic impact, for papers by Karl-Anders Karlsson Breakdown of academic impact, for papers by Sumit Mukherjee Breakdown of academic impact, for papers by Minjie Meng Breakdown of academic impact, for papers by Aqsa Ikram
Rankless by CCL
2026